drugset / Trial / NCT05705336

Clinical Trial Analyzing the Efficacy of Oral Administration of Tranexamic Acid in Spine Surgery.

NCT05705336

Phase 4 Completed 60 enrolled Alejandro Reyes Sánchez
RandomizedParallel-groupSingle-blindPrevention

Summary

Study design: Randomized control trial Purpose: Evaluate the efficacy of oral administration of tranexamic acid (TXA) in spine surgeries to achieve blood loss reduction. Methods. A total of 60 patients undergoing major surgery of the spine, were randomly assigned into 2 groups. Group 1 was assigned as the control group and the other one included oral administration of tranexamic acid 2 hours prior to surgery. Outcomes measures included intraoperative blood loss, postoperative blood loss, hematological parameters, blood transfusion needed, and surgical complications.

Timeline

Start
2021-01-01
Primary completion
2021-12-30
Completion
2022-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1950 mg Oral

Indications

No indication recorded.